메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Shinichiro Shinzaki (Osaka University Graduate School of Medicine) Toshimitsu Fujii (Tokyo Medical and Dental University) Shigeki Bamba (Shiga University of Medical Science) Maiko Ogawa (The Jikei University School of Medicine Katsushika Medical Center) Taku Kobayashi (Kitasato University Kitasato Institute Hospital) Masahide Oshita (Osaka Police Hospital) Hiroki Tanaka (Sapporo Kosei General Hospital) Keiji Ozeki (Nagoya City University Graduate School of Medical Sciences) Sakuma Takahashi (Kagawa Prefectural Central Hospital) Hiroki Kitamoto (Kobe City Medical Center General Hospital) Kazuhito Kani (Saitama Medical Center) Sohachi Nanjo (Graduate School of Medicine and Pharmaceutical Sciences University of Toyama) Takeshi Sugaya (Dokkyo Medical University) Yuko Sakakibara (National Hospital Organization Osaka National Hospital) Toshihiro Inokuchi (Okayama University Graduate School of Medicine) Kazuki Kakimoto (Osaka Medical College) Akihiro Yamada (Toho University Sakura Medical Center) Hisae Yasuhara (Mitoyo General Hospital) Yoko Yokoyama (Hyogo College of Medicine) Takuya Yoshino (Kitano Hospital) Akira Matsui (Toranomon Hospital) Misaki Nakamura (Mie University Graduate School of Medicine) Taku Tomizawa (Gunma University) Ryosuke Sakemi (Tobata Kyoritsu Hospital) Noriko Kamata (Osaka City University Graduate School of Medicine) Toshifumi Hibi (Kitasato University Kitasato Institute Hospital)
저널정보
대한장연구학회 Intestinal research Intestinal research Vol.16 No.4
발행연도
2018.1
수록면
609 - 618 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate the safety of H. pylori eradication therapy for IBD patients. Methods: IBD patients with H. pylori eradication from 2005 to 2015 (eradication group) and control patients (non-eradication group; 2 paired IBD patients without H. pylori eradication matched with each eradicated patient) were included. IBD exacerbation (increased/additional IBD drug or IBD-associated hospitalization/surgery) and disease improvement based on the physicians’ global assessment were investigated at baseline, and at 2 and 6 months after eradication or observation. Results: A total of 429 IBD (378 ulcerative colitis, 51 Crohn’s disease) patients, comprising 144 patients in the eradication group and 285 patients in the non-eradication group, were enrolled at 25 institutions. IBD exacerbation was comparable between groups (eradication group: 8.3% at 2 months [odds ratio, 1.76; 95% confidence interval, 0.78–3.92; P=0.170], 11.8% at 6 months [odds ratio, 1.60; 95% confidence interval, 0.81–3.11; P=0.172]). Based on the physicians’ global assessment at 2 months, none of the patients in the eradication group improved, whereas 3.2% of the patients in the non-eradication group improved (P=0.019). Multivariate analysis revealed that active disease at baseline, but not H. pylori eradication, was an independent factor for IBD exacerbation during 2 months’ observation period. The overall eradication rate was 84.0%–comparable to previous reports in non-IBD patients. Conclusions: H. pylori eradication therapy does not alter the short-term disease activity of IBD. (Intest Res 2018;16:609-618)

목차

등록된 정보가 없습니다.

참고문헌 (3)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0